Discoveries in HIV

In a cohort of patients with HIV, weight gain was linked to the use of certain types of ART, as well as a baseline diagnosis of hypertension, a researcher reported at IDWeek.

Most children and adolescents with HIV mounted antibody responses to the quadrivalent HPV vaccine, according to a study presented at IDWeek.

Patients with HIV on long-acting cabotegravir plus rilpivirine reported improved treatment satisfaction compared with daily ART at 96 weeks, according to results from the phase 3 FLAIR study.

Physicians should discuss risks associated with certain antiretroviral agents, such as dolutegravir, and contraception with women with HIV who are of childbearing age, researchers reported IDWeek.

Integrase strand transfer inhibitors are associated with an increased risk for weight gain and hyperglycemia or diabetes, according to data presented at IDWeek.

Researchers developed a statewide hepatitis C treatment cascade for people coinfected with HIV using statewide surveillance data, according to a presenter at IDWeek.

Despite guidelines recommending periodic laboratory testing in patients with HIV on ART, it may be beneficial to delay liver, renal and lipid testing in low-risk patients to minimize exposure to COVID-19, new data suggest.

New data from a systematic review and meta-analysis indicated that the prevalence of HIV was higher among patients hospitalized for COVID-19 than in the general population.

Only about half of patients who were seen at a sexual health center and subsequently referred to HIV PrEP attended an initial visit, indicating the need to fine-tune the PrEP referral process, researchers reported at IDWeek.

Among people with HIV and COVID-19, researchers linked noncommunicable comorbidities, such as diabetes and cardiovascular disease, as opposed to HIV alone, with an increased risk for hospitalization, according to a study presented at IDWeek.